Quintiles IMS Incorporated, founded in 1982 and headquartered in Durham, North Carolina, is a leading global provider of integrated information and technology solutions that help healthcare organizations accelerate the development and commercialization of new therapies. The company specializes in offering a variety of services, including clinical research, analytics, and consulting for the pharmaceutical and biotechnology sectors.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| RX 2.88% 2025-09-15 EURQuintiles IMS Incorporated | United States | 2025-09-15 | 2.875 | 4.40 |
| RX 2.88% 2025-09-15 EURQuintiles IMS Incorporated | United States | 2025-09-15 | 2.875 | 4.40 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Quintiles IMS has a significant history of bond issuances, with its first bonds being issued in the early 2000s to finance expansion efforts and acquisitions. Notably, in 2016, the company issued a $1 billion bond to fund the merger with IMS Health, enhancing its market position. Current yields on their bonds are competitive within the industry, offering attractive options for retail investors. Recent developments have suggested a focus on green bonds as part of their strategic initiatives, reflecting growing investor interest in sustainability.